Live Quote · NASDAQCYTKHealthcare· Biotechnology

Cytokinetics, Incorporated

$50.78▼ 1.32%($-0.68)
MKT CAP $7.07BNEXT EARNINGS Feb 23, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
20
Valuation
60
Profitability
55
Growth
64
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYTK research report →

Analyst Price Target
$107.14+111.0% vs. today

Range $81 – $118

Analyst RatingBuy
34 Buy1 Hold0 Sell

Price Chart

-20.57% · this period
$87.26$69.29$51.32Nov 19May 22Nov 19
52-Week Range1% of range
Low
$50.32
Current
$50.78
High
$88.31